Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

T

TSHA

Taysha Gene Therapies Inc

5.74

Aug 04 • 6:15 AM ET -0.04 (-0.69%)

Healthcare Biotechnology USA Small NASD

Peers: BEAM NTLA CRSP EDIT BMRN KRYS RYTM KYMR NUVL INCY

| Held by: VTI IWM XBI VXF IWO IBB VTWO SCHA FESM FYC

Scroll to Statements

Index	RUT
Market Cap	1.84B
Enterprise Value	1.63B
Income	-129.88M
Sales	7.47M
Book/sh	0.74
Cash/sh	0.87
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	99
IPO	Sep 24, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	245.78
P/B	7.78
P/C	6.63
P/FCF	-
EV/EBITDA	-
EV/Sales	217.91
Quick Ratio	14.03
Current Ratio	14.03
Debt/Eq	0.32
LT Debt/Eq	0.31
Option/Short	Yes / Yes

EPS (ttm)	-0.40
EPS next Y	-0.46
EPS next Q	-0.11
EPS this Y	-36.43%
EPS next Y	1.25%
EPS next 5Y	11.94%
EPS past 3/5Y	55.14% 36.86%
Sales past 3/5Y	57.49% -
EPS Y/Y TTM	-11.04%
Sales Y/Y TTM	3.42%
EPS Q/Q	-44.81%
Sales Q/Q	-100.00%
Earnings	May 06 BMO
EPS/Sales Surpr.	-24.10% -100.00%

Insider Own	17.11%
Insider Trans	-0.73%
Inst Own	82.04%
Inst Trans	-1.18%
ROA	-59.21%
ROE	-97.28%
ROIC	-46.61%
Gross Margin	84.51%
Oper. Margin	-1774.37%
Profit Margin	-1738.40%
SMA20	-1.65%
SMA50	-3.80%
SMA200	9.16%
Trades

Shs Outstand	287.28M
Shs Float	265.14M
Short Float	17.08%
Short Ratio	14.88
Short Interest	45.29M
52W High	7.30 -21.37%
52W Low	2.54 125.98%
Volatility	6.48% 7.49%
ATR (14)	0.41
RSI (14)	46.78
Beta	1.18
Rel Volume	0.00
Avg Volume	3.04M
Volume	39

Perf Week	5.13%
Perf Month	-10.03%
Perf Quarter	-13.55%
Perf Half Y	23.18%
Perf YTD	4.36%
Perf Year	111.81%
Perf 3Y	686.30%
Perf 5Y	-67.44%
Perf 10Y	-
Recom	1.08
Target Price	13.15
Prev Close	5.78
Price	5.74
Change	-0.69%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)